Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver

Drug Metabolism and Disposition

Volumn 27, Issue 2, 1999, Pages 188-192

  Chow, Toshio ^a   Imaoka, Susumu ^a   Hiroi, Toyoko ^a   Funae, Yoshihiko ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUFURALOL; CYTOCHROME P450; QUININE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CATALYSIS; ENZYME ACTIVITY; GENE EXPRESSION; HYDROXYLATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; ETHANOLAMINES; FEMALE; HYDROXYLATION; ISOENZYMES; KINETICS; LIVER; MALE; MICROSOMES, LIVER; MIXED FUNCTION OXYGENASES; QUININE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE;

ANIMALIA; CINCHONA PUBESCENS; SACCHAROMYCES CEREVISIAE;

EID: 0032911164     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brosen K, Klysner R, Gram LF, Otton SV, Bech P and Bertilsson L (1986) Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism. Eur J Clin Pharmacol 30:679-684.
2. Dayer P, Leemann T, Kupher A, Kronbach T and Meyer UA (1986) Stereo- and regioselectivity of hepatic oxidation in man: Effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation. Eur J Clin Pharmacol 31:313-318.
3. Eichelbaum E and Gross AS (1990) The genetic polymorphism of debrisoquine metabolism: Clinical aspects. Pharmacol Ther 46:377-394.
4. Funae Y and Imaoka S (1985) Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by high-performance liquid chromatography. Biochim Biophys Acta 842:119-132.
5. Gonzalez FJ, Matsunaga E, Nagata K, Meyer UA, Nebert DW, Pastewka J, Kozak CA, Gillette JI, Gelboin HV and Hardwick JP (1987) Debrisoquine 4-hydroxylase: Characterization of a new P450 gene subfamily, regulation, chromosomal mapping, and molecular analysis of the DNA rat polymorphism. DNA 6:149-161.
6. Gut J, Catin T, Dayer P, Kronbach T, Zanger U and Meyer UA (1986) Debrisoquine/sparteine-type polymorphism of drug oxidation. J Biol Chem 261:11734-11743.
7. Hiroi T, Imaoka S, Chow, T and Funae Y (1998) Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Biochim Biophys Acta 1380:305-312.
8. Imaoka S, Fujita S and Funae Y (1991) Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta 1097:187-192.
9. Kawashima H and Strobel HW (1995) cDNA cloning of a novel rat brain cytochrome P450 belonging to the CYP2D subfamily. Biochem Biophys Res Commun 209:535-540.
10. Kobliakov V, Popova N and Rossi L (1991) Regulation of the expression of the sex-specific isoforms of cylochrome P-450 in rat liver. Eur J Biochem 195:585-591.
11. Kronbach T, Mathys D, Gut J, Catin T and Meyer RA (1987) High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan o-demethylase in microsomal and purified cytochrome P-450 isozymes of human liver. Anal Biochem 162:24-32.
12. Maeda K, Kamataki T, Nagai T and Kato R (1984) Postnatal development of constitutive forms of cytochrome P-450 in liver microsomes of male and female rats. Biochem Pharmacol 33:509-512.
13. Matsunaga E and Gonzalez FJ (1990) Specific cytosine demethylation within the first exons of the rat CYP2D3 and CYP2D5 genes are associated with activation of hepatic gene expression during development. DNA Cell Biol 9:443-452.
14. Matsunaga E, Umeno M and Gonzalez FJ (1990) The rat debrisoquine 4-hydroxylase CYP2D gene subfamily: Complete sequences of four closely linked genes and evidence that gene conversions maintained sequence homogeneity at the heme binding region of the cytochrome P450 active site. J Mol Evol 30:155-169.
15. Matsunaga E, Zanger UM, Hardwick JP, Gelboin HV, Meyer UA and Gonzalez FJ (1989) The CYP2D gene subfamily: Analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry 28:7349-7355.
16. Oeda K, Sakaki T and Ohkawa H (1985) Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. DNA 4:203-210.
17. Ohishi N, Imaoka S, Suzuki T and Funae Y (1993) Characterization of two P-450 isozymes placed in the rat CYP2D subfamily. Biochim Biophys Acta 1158:227-236.
18. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2318.
19. Sakaki T, Akiyoshi-Shibata M, Yabusaki Y and Ohkawa H (1992) Organella-targeted expression of rat liver cytochrome P450c27 in yeast. Genetically engineered alteration of mitochondrial P450 into a microsomal form creates a novel functional electron transport chain. J Biol Chem 267:16497-16502.
20. Schenkman JB, Thummel KE and Favreau LV (1989) Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. Drug Metab Rev 20:557-584.
21. Tso JY, Sun XH, Kao TH, Reece KS and Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs : Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502.
22. Wan J, Imaoka S, Chow T, Hiroi T, Yabusaki Y and Funae Y (1997) Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic activity. Arch Biochem Biophys 348:383-390.
23. Waxman DJ, Dannan GA and Guengerich FP (1985) Regulation of rat hepatic cytochrome P-450 : Age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24:4409-4417.
24. Wrighton SA and Stevens JC (1992) The human hepatic cytochrome P450 involved in drug metabolism. Crit Rev Toxicol 22:1-21.